Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activation

American Journal of Veterinary Research

Volumn 72, Issue 11, 2011, Pages 1465-1475

  Dawson, Dominic R ^a,d   Nydam, Daryl V ^a   Price, Christopher T ^b   Graham, James E ^b   Cynamon, Michael H ^c   Divers, Thomas J ^a   Felippe, Maria Julia B ^a  

^a Cornell University ^*  (United States)

^b University of Louisville School of Medicine   (United States)

^c SYRACUSE VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BROTH DILUTION; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOAL; HORSE; HUMORAL IMMUNITY; INCUBATION TIME; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; OPSONIZATION; OXIDATIVE STRESS; PHAGOCYTE; PLASMA; RHODOCOCCUS EQUI;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BRONCHOPNEUMONIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HORSE DISEASES; HORSES; MACROPHAGES; MALE; MICROBIAL VIABILITY; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTES; PHAGOCYTOSIS; RESPIRATORY BURST; RHODOCOCCUS EQUI; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); EQUIDAE; RHODOCOCCUS EQUI;

EID: 80054878593     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.11.1465     Document Type: Article

References (65)

1. Horowitz ML, Cohen ND, Takai S, et al. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J Vet Intern Med 2001;15:171-175.
2. Chaffin MK, Cohen ND, Martens RJ, et al. Foal-related risk factors associated with development of Rhodococcus equi pneumonia on farms with endemic infection. J Am Vet Med Assoc 2003;223:1791-1799.
3. Giguère S, Prescott JF. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet Microbiol 1997;56:313-334.
4. Gürtler V, Mayall BC, Seviour R. Can whole genome analysis refine the taxonomy of the genus Rhodococcus? FEMS Microbiol Rev 2004;28:377-403.
5. Puech V, Chami M, Lemassu A, et al. Structure of the cell envelope of corynebacteria: importance of the non-covalently bound lipids in the formation of the cell wall permeability barrier and fracture plane. Microbiology 2001;147:1365-1382.
6. Hietala SK, Ardans AA. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet Microbiol 1987;14:302-320.
7. Hietala SK, Ardans AA. Neutrophil phagocytic and serum opsonic response of the foal to Corynebacterium equi. Vet Immunol Immunopathol 1987;14:279-294.
8. Toyooka K, Takai S, Kirikae T. Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J Med Microbiol 2005;54:1007-1015.
9. Fernandez-Mora E, Polidori M, Lührmann A, et al. Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic 2005;6:635-653.
10. Tan C, Prescott JF, Patterson MC, et al. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity. Can J Vet Res 1995;59:51-59.
11. Giguère S, Hondalus MK, Yager JA, et al. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun 1999;67:3548-3557.
12. Polidori M, Haas A. VapI, a new member of the Rhodococcus equi Vap family. Antonie Van Leeuwenhoek 2006;90:299-304.
13. Jain S, Bloom BR, Hondalus MK. Deletion of vapA encoding virulence associated protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol Microbiol 2003;50:115-128.
14. Hondalus MK, Mosser DM. Survival and replication of Rhodococcus equi in macrophages. Infect Immun 1994;62:4167-4175.
15. Wada R, Kamada M, Anzai T, et al. Pathogenicity and virulence of Rhodococcus equi in foals following intratracheal challenge. Vet Microbiol 1997;56:301-312.
16. Meijer WG, Prescott JF. Rhodococcus equi. Vet Res 2004;35:383-396.
17. Martens RJ, Fiske RA, Renshaw HW. Experimental subacute foal pneumonia induced by aerosol administration of Coryne-bacterium equi. Equine Vet J 1982;14:111-116.
18. Johnson JA, Prescott JF, Markham RJ. The pathology of experimental Corynebacterium equi infection in foals following intragastric challenge. Vet Pathol 1983;20:450-459.
19. Johnson JA, Prescott JF, Markham RJ. The pathology of experimental Corynebacterium equi infection in foals following intrabronchial challenge. Vet Pathol 1983;20:440-449.
20. Hooper-McGrevy KE, Wilkie BN, Prescott JF. Virulenceassociated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi. Vaccine 2005;23:5760-5767.
21. Dawson TR, Horohov DW, Meijer WG, et al. Current under-standing of the equine immune response to Rhodococcus equi. An immunological review of R. equi pneumonia. Vet Immunol Immunopathol 2010;135:1-11.
22. von Bargen K, Haas A. Molecular and infection biology of the horse pathogen Rhodococcus equi. FEMS Microbiol Rev 2009;33:870-891.
23. Jacks S, Giguère S, Crawford PC, et al. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin Vaccine Immunol 2007;14:669-677.
24. Jacks S, Giguère S, Prescott JF. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals. Clin Vaccine Immunol 2007b;14:369-374.
25. Flaminio MJ, Borges AS, Nydam DV, et al. The effect of CpG-ODN on antigen presenting cells of the foal. J Immune Based Ther Vaccines 2007;25:1-17.
26. Giguère S, Wilkie BN, Prescott JF. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect Immun 1999;67:5041-5047.
27. Uhl EW, Giguère S, Jack TJ, et al. Increased pulmonary activation of nuclear factor-κB (NF-κB) in foals inoculated with Rhodococcus equi is associated with increased expression of inflammatory cytokines. Vet Pathol 2002;39:132-136.
28. Flaminio MJ, Nydam DV, Marquis H, et al. Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection. Clin Vaccine Immunol 2009;16:176-183.
29. Khair OA, Davies RJ, Devalia JL. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996;9:1913-1922.
30. Martens RJ, Cohen ND, Jones SL, et al. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect Immun 2005;73:7040-7042.
31. Yager JA, Duder CK, Prescott JF, et al. The interaction of Rhodococcus equi and foal neutrophils in vitro. Met Microb 1987;14:287-294.
32. Martens RJ, Martens JG, Renshaw HW, et al. Rhodococcus equi: equine neutrophil chemiluminescent and bactericidal responses to opsonizing antibody. Vet Microbiol 1987;14:277-286.
33. Martens JG, Martens RJ, Renshaw HW. Rhodococcus (Corynebac-terium) equi: bactericidal capacity of neutrophils from neonatal and adult horses. Am J Vet Res 1988;49:295-299.
34. Martens RJ, Martens JG, Fiske RA, et al. Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals. Equine Vet J 1989;21:249-255.
35. Takai S, Hidaka D, Fujii M, et al. Serum antibody responses of foals to virulence-associated 15to 17-kilodalton antigens of Rhodococcus equi. Vet Microbiol 1996;52:63-71.
36. Hooper-McGrevy KE, Wilkie BN, Prescott JF. Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins. Clin Diagn Lab Immunol 2003;10:345-351.
37. Madigan JE, Hietala S, Muller N. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J Reprod Fertil Suppl 1991; (44):571-578.
38. Becu T, Polledo G, Gaskin JM. Immunoprophylaxis of Rhodococcus equi pneumonia in foals. Vet Microbiol 1997;56:193-204.
39. Cauchard J, Sevin C, Ballet JJ, et al. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet Microbiol 2004;104:73-81.
40. Caston SS, McClure SR, Martens RJ, et al. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococ-cus equi in experimentally infected foals. Vet Ther 2006;7:361-375.
41. Perkins GA, Yeager A, Erb HN, et al. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma. Vet Ther 2002;3:334-346.
42. Higuchi T, Arakawa T, Hashikura S, et al. Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection on foals from endemically affected farms. Zentralbl Veterinarmed B 1999;46:641-648.
43. Hurley JR, Begg AP. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust Vet J 1995;72:418-420.
44. Giguère S, Gaskin JM, Miller C, et al. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J Am Vet Med Assoc 2002;220:59-63.
45. Flaminio MJ, Rush BR, Davis EG, et al. Characterization of peripheral blood and pulmonary leukocyte function in healthy foals. Vet Immunol Immunopathol 2000;73:267-285.
46. Wellcome Trust Sanger Institute. Rhodococcus equi. Available at: www.sanger.ac.uk/resources/downloads/bacteria/rhodococcus-equi.html. Accessed June 15, 2008.
47. Cooksey RC, Crawford JT, Jacobs WR Jr, et al. A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother 1993;37:1348-1352.
48. Gröndahl G, Johannisson A, Demmers S, et al. Influence of age and plasma treatment on neutrophil phagocytosis and CD18 expression in foals. Vet Microbiol 1999;65:241-254.
49. Hondalus MK, Diamond MS, Rosenthal LA, et al. The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect Immun 1993;61:2919-2929.
50. Garton NJ, Gilleron M, Brando T, et al. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J Biol Chem 2002;277:31722-31733.
51. Zink MC, Yager JA, Prescott JF, et al. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol 1987;14:295-305.
52. Paulnock DM, Demick KP, Coller SP. Analysis of interferon-gamma-dependent and -independent pathways of macrophage activation. J Leukoc Biol 2000;67:677-682.
53. Schroder K, Sweet MJ, Hume DA. Signal integration between IFNγ and TLR signalling pathways in macrophages. Immunobiology 2006;211:511-524.
54. Kanaly ST, Hines SA, Palmer GH. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun 1995;63:3037-3041.
55. Kanaly ST, Hines SA, Palmer GH. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect Immun 1996;64:1126-1132.
56. Benoit S, Benachour A, Taouji S, et al. H(2)O(2), which causes macrophage-related stress, triggers induction of expression of virulence-associated plasmid determinants in Rhodococcus equi. Infect Immun 2002;70:3768-3776.
57. Darrah PA, Hondalus MK, Chen Q, et al. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 2000;68:3587-3593.
58. Vazquez-Torres A, Fang FC. Oxygen-dependent anti-Salmonella activity of macrophages. Trends Microbiol 2001;9:29-33.
59. Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1988;393:537-544.
60. Meighen E. Molecular biology of bacterial bioluminescence. Microbiol Rev 1991;55:123-142.
61. Carriere C, Riska P, Zimhony O, et al. Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 1997;35:3232-3239.
62. Riska P, Jacobs WR, Bloom B Jr, et al. Specific identification of Mycobacterium tuberculosis with the luciferase reporter myco-bacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J Clin Microbiol 1997;35:3225-3231.
63. Snewin VA, Gares MP, Gaora PO, et al. Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect Immun 1999;67:4586-4593.
64. Darrah PA, Monaco MCG, Jain S, et al. Innate immune responses to Rhodococcus equi. J Immunol 2004;173:1914-1924.
65. Giguère S, Prescott JF. Cytokine induction in murine macro-phages infected with virulent and avirulent Rhodococcus equi. Infect Immun 1998;66:1848-1854.